Organization · Venture Capital
HBM Partners AG
HBM Partners AG is a Swiss healthcare investor founded in 2001, focusing on venture, growth, and buy-out investments in biopharma, medtech, diagnostics, and healthcare sectors. The firm operates primarily in Europe and North America, with a global investment strategy.
Overview
What HBM Partners AG does
What HBM Partners AG is
HBM Partners AG is a Swiss healthcare investor founded in 2001, focusing on venture, growth, and buy-out investments in biopharma, medtech, diagnostics, and healthcare sectors. The firm operates primarily in Europe and North America, with a global investment strategy.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2001
- Approximate age
- About 25 years
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find HBM Partners AG elsewhere
Open the official website or a supported primary organization account.
Capability profile
HBM Partners AG as a funder
Investment thesis
HBM Partners AG focuses on investing in the healthcare sector, specifically biopharma, medtech, and diagnostics, with a preference for later-stage companies. The firm aims to support the growth of its portfolio through both private and public investments.
Focus narrative
HBM Partners invests in the biopharma, medtech, diagnostics, and healthcare sectors, engaging in venture, growth, and buy-out financings. Their investment amounts typically range from USD 10 million to 50 million, focusing on supporting the growth of portfolio companies through various stages of development, particularly in later-stage product and drug development.
Value beyond capital
HBM Partners adds value to its portfolio companies by leveraging its extensive network and expertise in the healthcare sector, providing strategic guidance and support throughout the growth process, and facilitating access to capital through both private and public markets.
Terms and economics
- Typical check
- $10,000,000–$50,000,000
Focus and fit
- Stages
- Growth Equity
- Regions
- AsiaEuropeNorth America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 100
Portfolio context
HBM Partners has a track record of over 100 investments, resulting in more than 60 trade sales and IPOs. The portfolio spans biopharma, medical devices, and diagnostics, showcasing a global diversification across Western Europe, the US, India, and China.
Common questions
What to know about HBM Partners AG
Upseed classifies HBM Partners AG under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.